This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other and unspecified types of non-Hodgkin lymphoma, hilmo
CD2_NONHODGKIN_NAS
non-Hodgkins lymphoma: Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1495 |
4. Check minimum number of eventsNone |
1495 |
5. Include endpointsNone |
1495 |
6. Filter based on genotype QC (FinnGen only) |
1495 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- C81-C96
- Name in latin
- Typi alii et non specificati lymphomatis non-Hodgkin
Similar endpoints
↥List of similar endpoints to
Other and unspecified types of non-Hodgkin lymphoma, hilmo
based on the number of shared cases.
Similar with more cases:
- Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers
- Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1495 | 673 | 822 |
| Unadjusted period prevalence (%) | 0.30 | 0.23 | 0.36 |
| Median age at first event (years) | 64.96 | 64.13 | 65.64 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1362
- Matched controls
- 13621
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
323.0
414
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
16384.0
323.0
784
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
87.1
323.0
872
272
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
145.9
323.0
451
46
L03AA02
ATC
filgrastim; parenteral
34.3
269.1
356
139
XW000
NOMESCO Finland
Bone marrow biopsy
17.4
223.4
371
286
M04AA01
ATC
allopurinol; systemic
6.5
176.7
562
1325
JN4BD
NOMESCO Finland
Extensive body CT
7.4
176.2
488
950
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
14.1
171.0
309
278
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
24.4
171.0
248
123
L03AA13
ATC
pegfilgrastim; parenteral
17.4
168.1
276
196
A03FA01
ATC
metoclopramide; systemic, rectal
5.2
152.2
607
1809
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
31.1
152.1
205
77
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
36.3
135.1
175
55
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
129.2
122
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
16.2
122.6
205
147
C82.1
ICD-10 Finland
Follicular lymphoma grade II
69.0
119.6
137
22
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
117.4
111
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
195.2
105.0
108
6
WW500
NOMESCO Finland
Blood transfusion
9.4
102.6
225
280
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
99.6
100.7
110
12
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
23.2
100.0
146
70
PJA10
NOMESCO Finland
Exploration of lymph nodes
27.6
98.8
137
55
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
140.5
98.5
104
8
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.9
95.0
257
441
A04AA01
ATC
ondansetron; systemic, rectal
6.9
94.2
255
438
JN6AD
NOMESCO Finland
CT of torso and neck
25.3
93.6
133
58
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
243.4
89.6
91
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
32.4
87.4
116
39
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
192.5
87.3
90
5
C83.1
ICD-10 Finland
Mantle cell lymphoma
53.2
82.9
99
20
1XC02
NOMESCO Finland
NA
31.9
81.9
109
37
JN4AD
NOMESCO Finland
Body CT examination
5.4
79.1
265
587
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
19.4
78.3
121
68
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.3
77.8
335
963
ZX120
NOMESCO Finland
Intravenous
4.6
73.1
289
759
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
93.1
71.8
79
9
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
116.5
71.7
77
7
R50.9
ICD-10 Finland
Fever, unspecified
3.9
70.8
342
1080
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
88.2
67.7
75
9
C83.00
ICD-10 Finland
Lymphocytic lymphoma
59.0
66.5
78
14
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.4
66.4
167
252
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
+∞
66.2
63
*
H02AB07
ATC
prednisone; oral
3.6
65.9
350
1188
D70.82
ICD-10 Finland
Drug-induced neutropenia
14.2
64.9
113
86
H02AB06
ATC
prednisolone; systemic
2.7
64.7
801
4747
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
23.7
64.5
93
42
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
12.5
60.7
112
97
H02AB02
ATC
dexamethasone; systemic
3.9
57.4
265
790
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
39.9
57.2
72
19
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
287.4
54.6
55
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.6
54.3
170
340
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
83.4
50.3
56
7
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
60.5
49.8
58
10
A04AA02
ATC
granisetron; systemic, transdermal
4.7
49.6
183
437
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
93.7
49.2
54
6
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
48.6
292
1061
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
15.4
47.9
80
55
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
6.5
46.4
127
213
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
13.6
46.1
81
63
L03AA14
ATC
lipegfilgrastim; parenteral
11.7
45.6
86
78
J05AB11
ATC
valaciclovir; oral
3.2
44.6
273
998
J01MA12
ATC
levofloxacin; systemic
2.7
44.3
375
1691
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
18.8
44.0
68
38
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.7
42.1
153
358
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
+∞
41.9
40
*
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
+∞
41.9
40
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
40.3
718
4636
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
18.5
40.0
62
35
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.3
39.6
515
2874
N02AA05
ATC
oxycodone; systemic
2.6
38.3
323
1433
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
40.5
37.7
47
12
C85.0
ICD-10 Finland
Lymphosarcoma
+∞
37.7
36
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
8.5
37.1
83
103
WW300
NOMESCO Finland
Transfer of autologic stem cells
24.7
35.5
50
21
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
126.6
34.8
37
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
126.6
34.8
37
*
ZX112
NOMESCO Finland
Subcutaneous
7.3
34.8
86
125
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.1
34.2
97
170
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
15.3
33.8
56
38
A02BC02
ATC
pantoprazole; systemic
2.0
33.2
933
7010
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.3
31.8
78
112
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
8.9
30.9
67
79
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.5
30.6
93
178
D70.89
ICD-10 Finland
Neutropenic splenomegaly
12.4
30.4
55
46
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
+∞
30.3
29
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.2
30.3
97
197
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
29.5
352
1835
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
29.3
28
*
A41.9
ICD-10 Finland
Sepsis, unspecified
4.6
29.2
106
246
L01AA02
ATC
chlorambucil; oral
26.7
28.5
39
15
212
Kela drug reimbursment
Gout
5.7
28.3
84
156
A07AA02
ATC
nystatin; oral
3.4
28.2
147
470
B72
ICPC
Hodgkin Lymphoma
79.3
27.9
31
*
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
287.1
27.8
28
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
8.3
27.6
62
78
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
35.9
27.5
35
10
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
12.0
27.3
50
43
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.4
27.3
138
431
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.0
26.2
86
180
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
25.9
173
656
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
9.6
25.4
52
56
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.0
24.3
100
262
TGC00
NOMESCO Finland
Bronchial lavation
5.1
24.2
78
160
J05AB01
ATC
aciclovir; systemic
2.1
24.0
308
1640
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
23.1
409
2471
WF004
NOMESCO Finland
Palliative radiotherapy
6.2
23.0
63
106
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.0
22.9
137
482
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
21.8
390
2355
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
223.4
21.7
22
*
4701
FHL
Neck lymph node removal
44.1
21.4
26
6
JN4CD
NOMESCO Finland
Very extensive body CT
3.6
21.0
100
297
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
61.0
20.9
24
*
9591/3-C16.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of stomach, NOS
+∞
20.9
20
*
9591/3-C77.8
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions
213.0
20.6
21
*
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
213.0
20.6
21
*
ZX108
NOMESCO Finland
Inhalation
11.5
20.5
38
34
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
9.0
20.4
43
49
Z51.5
ICD-10 Finland
Palliative care
2.8
20.3
135
509
C83
ICD-10 Finland
Non-follicular lymphoma
+∞
19.8
19
*
9591/3-C42.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of bone marrow
106.6
19.6
21
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
46.7
19.2
23
5
WF002
NOMESCO Finland
Radical radiotherapy
3.1
19.2
111
382
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.0
19.0
115
408
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
55.8
19.0
22
*
TAB00
NOMESCO Finland
Lumbar puncture
3.7
18.8
83
232
2000A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]
+∞
18.8
18
*
B01AB05
ATC
enoxaparin; parenteral
1.8
18.5
452
3000
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.6
18.0
42
57
WW200
NOMESCO Finland
Immunization
4.4
18.0
66
156
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
17.8
193
944
9591/3-C77.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes
+∞
17.7
17
*
C83.8
ICD-10 Finland
Other non-follicular lymphoma
+∞
17.7
17
*
9591/3-C09.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of tonsil, NOS
+∞
17.7
17
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.9
17.6
110
398
GEA00
NOMESCO Finland
Mediastinoscopy
17.2
17.4
27
16
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
17.4
330
2009
127
Kela drug reimbursment
Transplant complication
7.1
17.2
42
61
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
17.6
17.0
26
15
XX3DW
NOMESCO Finland
Time consuming IT work
2.3
16.2
165
782
YNB10
NOMESCO Finland
Collection of stem cells for transplant
30.4
16.1
21
7
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
16.1
415
2776
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
60.7
15.8
18
*
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
26.6
15.6
21
8
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
86.1
15.6
17
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
86.1
15.6
17
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
161.7
15.5
16
*
J01MA14
ATC
moxifloxacin; systemic
2.4
15.3
141
636
EBA10
NOMESCO Finland
Surgical removal of tooth
2.4
15.2
136
604
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
29.0
15.2
20
7
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
45.5
15.1
18
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.2
14.9
57
141
J02AC01
ATC
fluconazole; systemic
1.7
14.9
438
3028
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
14.9
134
599
EMA10
NOMESCO Finland
Biopsy of tonsil
25.3
14.7
20
8
WW409
NOMESCO Finland
Other aferesis
25.3
14.7
20
8
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
14.6
169
847
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
13.5
14.2
24
18
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
5.9
14.1
39
68
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.8
13.9
58
156
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
7.9
13.9
31
40
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
17.7
13.8
21
12
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
24.1
13.8
19
8
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
10.6
13.7
26
25
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
75.9
13.6
15
*
C82.0
ICD-10 Finland
Follicular lymphoma grade I
75.9
13.6
15
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
13.5
279
1727
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
13.5
235
1377
9699/3-C16.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of stomach, NOS
141.3
13.5
14
*
N05CF01
ATC
zopiclone; oral
1.6
13.3
459
3283
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
21.4
13.3
19
9
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.7
13.3
93
360
D69.5
ICD-10 Finland
Secondary thrombocytopenia
13.9
13.2
22
16
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
13.2
592
4516
390
Kela drug reimbursment
Ibrutinib
40.5
13.2
16
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
40.5
13.2
16
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
13.1
159
814
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
8.9
13.0
27
31
JMA10
NOMESCO Finland
Transabdominal total splenectomy
10.2
13.0
25
25
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
50.5
12.9
15
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
50.5
12.9
15
*
9591/3-C77.4
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg
70.5
12.6
14
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.5
12.6
58
170
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
32.3
12.6
16
5
ZXE00
NOMESCO Finland
One hour or less
1.6
12.5
500
3697
TPX15
NOMESCO Finland
Removal of vascular injection port
11.1
12.5
23
21
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
12.5
12
*
9591/3-C77.3
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm
+∞
12.5
12
*
9101
FHL
Bone biopsy
24.5
12.5
17
7
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.1
12.3
66
217
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
14.5
12.3
20
14
L01CB01
ATC
etoposide; systemic
10.6
12.3
23
22
B01AB10
ATC
tinzaparin; parenteral
2.4
12.3
106
463
B02.9
ICD-10 Finland
Zoster without complication
2.6
12.2
93
379
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
26.9
12.1
16
6
3AA13
NOMESCO Finland
NA
21.5
12.0
17
8
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
10.1
12.0
23
23
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
6.0
12.0
32
54
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
6.9
11.9
29
43
1512
Kela drug reimbursment
Ibrutinib
47.1
11.9
14
*
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
8.5
11.8
25
30
WX110
NOMESCO Finland
Local anesthesy
1.5
11.6
793
6569
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
65.5
11.6
13
*
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
65.5
11.6
13
*
1BC01
NOMESCO Finland
NA
+∞
11.5
11
*
9680/3-C16.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of stomach, NOS
121.0
11.4
12
*
C83.71
ICD-10 Finland
Burkitt's tumour
121.0
11.4
12
*
Z3231
NOMESCO Finland
Registered nurse
1.6
11.4
373
2617
V03AF03
ATC
calcium folinate; systemic
15.2
11.3
18
12
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
8.4
11.3
24
29
A02BA02
ATC
ranitidine; systemic
1.7
11.2
288
1891
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
25.2
11.1
15
6
1AA09
NOMESCO Finland
NA
20.2
11.1
16
8
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
6.5
11.1
28
44
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
6.1
11.1
29
48
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
7.1
11.1
26
37
Z2446
NOMESCO Finland
Social worker
2.4
10.9
90
385
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.0
10.8
34
70
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
15.6
10.8
17
11
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
10.8
475
3564
C03CA01
ATC
furosemide; systemic
1.5
10.8
454
3372
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
18.0
10.7
16
9
Z2221
NOMESCO Finland
Medical doctor
1.6
10.7
349
2442
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
60.5
10.6
12
*
C82
ICD-10 Finland
Follicular lymphoma
60.5
10.6
12
*
FM1FN
NOMESCO Finland
Heart function isotope examination
10.1
10.5
20
20
9680/3-C77.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck
+∞
10.4
10
*
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
10.4
10
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
10.4
242
1547
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.2
10.4
38
92
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
32.8
10.3
13
*
A79
ICPC
Malignancy NOS
4.5
10.3
35
79
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
18.9
10.3
15
8
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
9.6
10.3
20
21
WW402
NOMESCO Finland
Leucoferesis
23.5
10.2
14
6
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
23.5
10.2
14
6
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
10.2
151
832
JAL00
NOMESCO Finland
Biopsy of peritoneum
10.1
10.0
19
19
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
9.8
142
774
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.6
9.8
69
269
H02AB09
ATC
hydrocortisone; systemic
3.9
9.7
39
103
GD1AD
NOMESCO Finland
Thorax CT examination
2.6
9.6
70
281
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
11.5
9.6
17
15
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
15.1
9.5
15
10
WZC30
NOMESCO Finland
Teaching
1.8
9.4
173
1027
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
100.7
9.4
10
*
9698/3-C77.9
ICD-O-3
Follicular lymphoma, grade 3 of lymph node, NOS
30.2
9.4
12
*
JAH20
NOMESCO Finland
Staging laparotomy
30.2
9.4
12
*
N05BA06
ATC
lorazepam; systemic, sublingual
2.4
9.4
79
340
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.5
9.4
42
122
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
9.4
9
*
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
+∞
9.4
9
*
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
+∞
9.4
9
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
9.3
466
3562
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
9.2
236
1546
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
36.9
9.0
11
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
9.0
399
2972
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.9
9.0
128
698
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
8.9
151
871
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
24.2
8.9
12
5
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
8.9
135
753
R4110
NOMESCO Finland
Physiotherapy
1.5
8.9
333
2394
JAH01
NOMESCO Finland
Laparoscopy
2.7
8.8
57
215
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.9
8.8
34
88
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
8.7
214
1385
A02BC01
ATC
omeprazole; systemic
1.5
8.7
362
2659
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
50.3
8.7
10
*
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
50.3
8.7
10
*
L01EL01
ATC
ibrutinib; oral
50.3
8.7
10
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
11.6
8.6
15
13
A05AA02
ATC
ursodeoxycholic acid; oral
4.8
8.6
27
57
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.5
8.6
65
267
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.7
8.5
55
207
N03AX16
ATC
pregabalin; oral
1.5
8.5
288
2020
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
27.7
8.5
11
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.7
8.5
35
96
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
8.5
116
622
9680/3-C42.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of spleen
90.6
8.4
9
*
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
90.6
8.4
9
*
9698/3-C77.8
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of multiple regions
90.6
8.4
9
*
9690/3-C77.8
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of multiple regions
90.6
8.4
9
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
90.6
8.4
9
*
WX002
NOMESCO Finland
Sedation and analgesia
1.6
8.4
254
1731
9691/3-C77.8
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of multiple regions
+∞
8.3
8
*
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
8.3
8
*
C83.70
ICD-10 Finland
Non-Hodgkin's lymphoma of the Burkitt type
+∞
8.3
8
*
2019X
ICD-9 Finland
Hodgkin's disease, unspecified
+∞
8.3
8
*
9591/3-C07.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of parotid gland
+∞
8.3
8
*
C83.51
ICD-10 Finland
B-lymphoblastic lymphoma or leukemia
+∞
8.3
8
*
9699/3-C42.1
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of bone marrow
+∞
8.3
8
*
C83.5
ICD-10 Finland
Lymphoblastic (diffuse) lymphoma
+∞
8.3
8
*
6103
FHL
Staging laparotomy (to study the reticuloendothelial system)
+∞
8.3
8
*
ZXA05
NOMESCO Finland
Left side
1.5
8.3
342
2501
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
8.6
8.3
17
20
6BA02
NOMESCO Finland
NA
10.8
8.3
15
14
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.0
8.3
31
78
N02AX02
ATC
tramadol; systemic, rectal
1.4
8.2
538
4310
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
8.2
423
3238
KFC00
NOMESCO Finland
Unilateral orchiectomy
7.6
8.2
18
24
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.9
8.2
47
164
CAA30
NOMESCO Finland
Biopsy of orbit
33.5
8.1
10
*
L01XE27
ATC
[U] ibrutinib; oral
33.5
8.1
10
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
5.1
8.0
24
48
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
8.0
122
679
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
5.3
8.0
23
44
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
8.0
103
542
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.6
7.9
34
97
120
Kela drug reimbursment
Hypogammaglobulinaemia
13.1
7.9
13
10
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
13.1
7.9
13
10
2392A
ICD-9 Finland
Neoplasm of unspecified nature, Bone, soft tissue and skin
13.1
7.9
13
10
E83.50
ICD-10 Finland
Hypercalcemia
4.7
7.8
25
54
L04AA01
ATC
[U] ciclosporin; systemic
4.7
7.8
25
54
R06AE07
ATC
cetirizine; oral
1.4
7.8
473
3729
EMB10
NOMESCO Finland
Tonsillectomy
2.7
7.7
50
189
GD6AD
NOMESCO Finland
CT of chest and neck
15.1
7.7
12
8
C90.0
ICD-10 Finland
Multiple myeloma
4.1
7.6
28
70
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
11.9
7.6
13
11
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
25.1
7.6
10
*
D73.9
ICD-10 Finland
Disease of spleen, unspecified
25.1
7.6
10
*
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
25.1
7.6
10
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.6
7.5
32
91
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.6
7.4
51
198
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
80.5
7.4
8
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
80.5
7.4
8
*
9663/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS
80.5
7.4
8
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
7.4
212
1422
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
13.4
7.4
12
9
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.8
7.4
44
159
N03AX14
ATC
levetiracetam; systemic
3.0
7.3
39
131
J01DB01
ATC
cefalexin; oral
1.4
7.3
996
8972
ED1AA
NOMESCO Finland
Mandipular X-ray examination
6.9
7.3
17
25
C83.6
ICD-10 Finland
Undifferentiated (diffuse) non-Hodgkin's lymphoma
+∞
7.3
7
*
9650/3-C77.1
ICD-O-3
Hodgkin lymphoma, NOS, of intrathoracic lymph nodes
+∞
7.3
7
*
V03AB28
ATC
NA
+∞
7.3
7
*
9670/3-C77.0
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck
+∞
7.3
7
*
C85
ICD-10 Finland
Other and unspecified types of non-Hodgkin lymphoma
+∞
7.3
7
*
9680/3-C77.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm
+∞
7.3
7
*
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
3.3
7.3
34
104
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.1
7.3
76
368
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
5.2
7.3
21
41
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
5.8
7.2
19
33
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
7.2
474
3777
AAA10
NOMESCO Finland
Biopsy through craniotomy
30.2
7.1
9
*
L01BB05
ATC
fludarabine; systemic
20.1
7.1
10
5
1CX01
NOMESCO Finland
NA
20.1
7.1
10
5
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
12.1
7.1
12
10
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
12.1
7.1
12
10
CFA20
NOMESCO Finland
Biopsy of conjunctiva
12.1
7.1
12
10
Z51.88
ICD-10 Finland
Other specified medical care
3.2
7.1
35
112
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.1
7.0
36
118
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
10.1
7.0
13
13
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.6
6.9
22
48
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.4
6.9
55
234
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
6.7
6.8
16
24
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.8
6.8
40
144
9680/3-C77.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes
40.2
6.8
8
*
PA7ST
NOMESCO Finland
Extensive medical infusion to cerebral artery
40.2
6.8
8
*
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
40.2
6.8
8
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
16.8
6.7
10
6
J01MA01
ATC
ofloxacin; systemic
1.7
6.7
124
739
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.4
6.7
54
231
L04AA06
ATC
mycophenolic acid; systemic
3.8
6.7
26
69
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.7
6.7
43
162
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
22.6
6.7
9
*
PJ2HT
NOMESCO Finland
Biopsy of deep lymphnode with ultrasound guidance
22.6
6.7
9
*
2390A
ICD-9 Finland
Neoplasm of unspecified nature, Digestive system
7.8
6.6
14
18
A07AA09
ATC
vancomycin; oral
4.1
6.6
24
60
ZX114
NOMESCO Finland
Intramuscular
3.8
6.6
26
70
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
12.3
6.6
11
9
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
12.3
6.6
11
9
ZX130
NOMESCO Finland
Epidural
10.1
6.5
12
12
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
4.5
6.5
21
47
ZXD05
NOMESCO Finland
Urgent procedure
1.4
6.5
373
2894
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
6.5
60
274
5701
FHL
Local exploration of lymph nodes (includes biopsy)
70.1
6.4
7
*
20199
ICD-8 Finland
Hodgkin's disease
70.1
6.4
7
*
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
70.1
6.4
7
*
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
14.4
6.4
10
7
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
8.2
6.3
13
16
TGD00
NOMESCO Finland
Needle biopsy of lung
8.2
6.3
13
16
B03XA02
ATC
darbepoetin alfa; parenteral
3.1
6.3
32
105
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.1
6.3
31
100
9691/3-C77.0
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of head, face and neck
+∞
6.3
6
*
AAF30
NOMESCO Finland
Implantation of intraventricular injection device
+∞
6.3
6
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
6.3
6
*
9690/3-C77.0
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of head, face and neck
+∞
6.3
6
*
9591/3-C71.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS
+∞
6.3
6
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
6.2
54
241
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.3
6.2
21
49
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
26.8
6.2
8
*
HA1AA
NOMESCO Finland
X-ray mammography
1.9
6.2
83
445
J35.1
ICD-10 Finland
Hypertrophy of tonsils
5.1
6.2
18
36
WX882
NOMESCO Finland
High dependency care
2.6
6.1
41
160
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
8.6
6.1
12
14
JAH00
NOMESCO Finland
Laparotomy
2.5
6.0
43
173
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
1.9
6.0
89
492
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
593
1141
7.96
322.01
1.5
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
527
648
12.02
307.65
1.4
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
306
107
35.70
307.65
1.4
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
853
1522
11.72
307.65
8.2
4.2
u/l
270.0
251.1
1.41
830
1431
(3045142) Bone marrow Pathology biopsy report
269
151
21.50
307.65
1.5
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
231
83
32.73
307.65
1.4
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
574
1030
8.42
307.65
1.5
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
626
1372
7.13
296.58
1.6
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
265
237
13.37
260.25
1.8
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
192
97
22.56
254.27
2.8
2.0
e9/l
1.2
1.0
0.76
140
57
(4035726)
514
1068
6.81
252.77
1.8
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
437
865
6.73
223.41
4.3
2.9
g/l
8.9
10.8
10.78
419
790
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
156
67
25.88
220.02
2.4
2.0
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
160
74
24.09
219.24
2.3
2.0
%
73.0
70.6
0.45
155
69
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
159
73
24.25
218.50
2.3
2.0
%
15.4
15.7
0.04
62
30
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
194
180
12.24
184.45
3.7
2.8
u/ml
11707.9
2203.4
0.54
29
19
(21494815) CD4 cells/100 lymphocytes in Specimen
138
78
19.39
172.78
2.4
1.9
%
22.5
41.5
—
8
12
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
198
232
9.68
158.98
6.7
6.0
iu/ml
6920.5
868.6
0.43
33
34
(3028026) IgM [Mass/volume] in Serum or Plasma
331
694
5.84
155.49
3.4
1.8
g/l
1.7
1.6
0.20
316
634
(3026493) Urate [Moles/volume] in Serum or Plasma
781
3281
3.89
146.78
6.0
2.8
umol/l
3577.3
7164.0
1.43
743
2794
(42870588) Differential panel, method unspecified - Blood
888
4082
3.89
145.32
10.8
5.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1041
5344
4.12
143.88
11.1
5.8
%
0.7
0.7
0.20
1004
4946
(3006504) Eosinophils/100 leukocytes in Blood
1052
5485
4.10
140.97
11.3
5.8
%
2.6
2.8
2.66
1019
5071
(3019069) Monocytes/100 leukocytes in Blood
1053
5503
4.09
140.39
11.9
6.1
%
9.4
8.9
4.49
1017
5104
(40765096) Chromosome analysis panel by Banding
102
47
23.22
139.16
1.2
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1086
5835
4.15
137.99
10.4
5.6
e9/l
0.0
0.0
2.14
984
4973
(3001604) Monocytes [#/volume] in Blood
1083
5817
4.13
137.46
10.4
5.6
e9/l
0.6
0.6
0.32
982
4947
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
113
68
17.89
136.90
3.1
2.2
e6/l
629.2
618.9
0.03
98
61
(21494814) CD8 cells/100 lymphocytes in Specimen
95
39
25.94
135.46
2.2
1.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1053
5610
3.97
133.82
11.7
6.0
%
27.4
26.5
1.16
1015
5172
(3013115) Eosinophils [#/volume] in Blood
1098
6026
4.10
133.18
11.3
5.8
e9/l
0.2
0.2
8.73
1001
5227
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
87
30
30.73
131.66
2.2
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1085
5947
4.01
130.89
10.6
5.6
e9/l
2.0
1.9
0.36
997
5174
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
109
67
17.47
130.60
3.2
2.3
e9/l
0.2
0.2
0.18
98
61
(3018010) Neutrophils/100 leukocytes in Blood
1035
5508
3.86
130.41
10.7
5.8
%
56.9
58.1
2.08
1001
5112
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
107
71
16.16
123.20
3.5
2.2
e6/l
441.6
697.8
1.66
43
33
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
159
205
8.56
117.56
1.3
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
101
73
14.77
110.89
3.6
2.9
%
35.9
36.1
0.01
40
27
(3017181) Myelocytes/100 leukocytes in Blood
353
1014
4.25
110.64
7.2
4.2
%
1.0
0.9
0.24
211
317
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
140
178
8.57
104.48
1.4
1.4
u/ml
106.6
135.7
0.49
36
29
(3013650) Neutrophils [#/volume] in Blood by Automated count
1115
6822
3.50
100.23
23.8
8.9
e9/l
3.7
4.2
10.44
1029
5921
(3027945) Reticulocytes/100 erythrocytes in Blood
445
1595
3.55
100.10
4.3
2.4
%
1.8
1.8
0.36
407
1405
(3021440) Promyelocytes/100 leukocytes in Blood
320
957
3.98
93.71
7.4
4.2
%
0.2
0.1
0.78
194
291
(3002179) Metamyelocytes/100 leukocytes in Blood
308
916
3.98
90.71
6.9
4.0
%
0.6
0.5
0.18
148
230
(3004809) Band form neutrophils/100 leukocytes in Blood
141
213
7.20
90.41
5.1
3.9
%
2.1
1.4
0.80
121
167
(3023520) Reticulocytes [#/volume] in Blood
356
1183
3.64
88.95
4.2
2.6
e9/l
70.6
69.3
0.26
303
932
(3006245) CD3-CD19+ cells/100 cells in Blood
67
35
19.99
86.28
2.3
2.3
%
9.9
12.9
0.31
60
29
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1049
6503
3.06
85.68
14.8
6.3
umol/l
10.9
12.0
1.86
1027
6136
(3004588) Protein electrophoresis panel - Serum or Plasma
302
945
3.75
82.08
2.8
2.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
491
2073
3.04
81.83
6.8
3.2
mmol/l
0.8
0.8
0.78
469
1933
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
170
351
5.34
79.07
1.7
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
333
1142
3.46
78.41
3.2
2.8
g/l
63.7
66.2
5.45
314
1037
(3024561) Albumin [Mass/volume] in Serum or Plasma
926
5570
2.74
76.38
8.5
4.9
g/l
34.0
34.9
4.55
887
5145
(3025159) Blasts/100 leukocytes in Blood
284
898
3.67
75.59
6.9
4.3
%
0.0
0.4
0.63
155
246
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
150
313
5.22
68.71
2.8
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
152
327
5.06
67.19
2.6
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
686
3758
2.53
65.54
8.8
4.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
47
21
23.07
64.40
1.4
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
124
243
5.47
60.81
2.7
1.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
401
1744
2.78
60.81
7.4
5.7
mmol/l
1.1
1.0
0.83
384
1601
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
968
6364
2.48
59.89
11.5
6.8
mmol/l
1.2
1.2
5.72
825
5318
(3048929) Epstein Barr virus Ab [Presence] in Serum
130
273
5.12
58.95
1.3
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
44
22
20.58
57.52
2.3
2.1
e6/l
1798.4
203.3
—
19
6
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
108
203
5.66
55.35
1.3
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
173
485
3.90
54.11
2.5
2.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
887
5846
2.27
51.04
10.1
6.1
mmol/l
1.2
1.2
5.28
850
5244
(3007164) IgA [Mass/volume] in Serum or Plasma
416
1999
2.50
50.24
2.5
1.5
g/l
2.0
2.6
9.07
329
1172
(40760892) CBC W Ordered Manual Differential panel - Blood
472
2402
2.41
50.24
10.0
4.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
98
192
5.39
47.94
1.2
1.2
u/ml
315.1
286.9
0.23
60
107
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
73
108
7.05
47.37
1.9
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
44
33
13.71
46.94
4.4
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
536
2961
2.26
46.44
17.1
6.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
97
195
5.25
46.09
2.0
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
105
228
4.88
45.63
2.0
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
60
76
8.18
44.53
4.7
3.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
84
153
5.76
44.43
6.7
4.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
435
2237
2.33
44.35
2.9
1.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
63
85
7.69
44.34
1.3
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
635
3808
2.16
44.33
8.3
4.1
ph
7.4
7.4
0.01
153
737
(3032352) Blasts [#/volume] in Cerebral spinal fluid
30
11
27.81
43.92
1.6
3.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
79
138
5.99
43.63
2.9
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
76
128
6.20
43.55
2.9
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
789
5174
2.11
43.22
18.2
10.1
e9/l
0.0
0.0
0.63
674
4196
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
32
15
21.78
42.80
2.1
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
117
293
4.25
42.49
1.9
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
726
4636
2.10
42.44
2.7
2.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
690
4329
2.10
42.22
6.7
3.5
mmol/l
2.4
2.3
0.18
633
3712
(44790049)
76
135
5.88
41.24
2.1
1.5
—
—
—
0
0
(44790047)
76
135
5.88
41.24
2.1
1.5
—
—
—
0
0
(44806118)
76
135
5.88
41.24
2.1
1.5
—
—
—
0
0
(44790048)
76
135
5.88
41.24
2.1
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
64
97
6.85
40.58
2.5
2.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
44
43
10.51
39.68
2.4
2.8
u/ml
6848.1
55782.9
—
9
8
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
87
184
4.96
38.95
1.9
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
61
93
6.80
38.46
1.3
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
631
3935
2.04
38.18
4.3
2.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
325
1567
2.37
37.71
2.6
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
234
975
2.66
37.04
2.6
1.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
142
447
3.41
37.00
3.0
2.7
g/l
1.7
1.4
0.30
123
386
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
78
157
5.19
36.95
2.2
1.7
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
144
458
3.37
36.91
3.6
3.8
mg/l
38.1
72.1
0.66
119
371
(3037756) Immunofixation for Serum or Plasma
113
309
3.87
36.33
1.6
1.7
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
72
137
5.47
36.30
5.8
3.9
%
50.6
55.5
0.69
50
93
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
155
526
3.17
35.71
2.8
2.6
g/l
3.6
3.8
0.47
115
382
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
148
489
3.25
35.64
2.9
2.6
g/l
3.3
3.1
1.22
117
388
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
155
527
3.17
35.59
2.8
2.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
155
527
3.17
35.59
2.8
2.6
g/l
7.1
7.4
1.09
120
394
(3034860) Kappa light chains.free [Mass/volume] in Serum
142
458
3.32
35.57
3.6
3.7
mg/l
68.8
65.9
0.06
117
369
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
140
449
3.34
35.38
3.6
3.7
ratio
7.0
1.6
1.16
15
40
(3037692) Legionella sp identified in Specimen by Organism specific culture
42
46
9.37
34.88
1.3
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
318
1573
2.30
34.47
2.8
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1124
8795
2.12
34.02
6.9
4.1
mm/h
17.2
13.7
7.98
1072
8032
(40760888) Immunoglobulin light chains.free panel - Serum
115
338
3.60
33.25
3.4
4.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
438
2511
2.05
32.34
5.0
3.1
mmol/l
2.5
2.5
3.82
419
2193
(3033658) Prothrombin time (PT) actual/Normal
515
3130
1.98
32.24
6.1
4.0
%
86.8
86.0
0.30
503
3054
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
124
392
3.36
32.02
3.2
2.5
g/l
0.0
0.0
0.26
118
357
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
802
5662
1.90
31.81
6.7
4.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1165
9346
2.12
31.42
18.9
7.7
u/l
83.2
79.4
1.55
1144
8726
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
168
645
2.81
30.95
2.2
1.8
g/l
1.6
1.5
0.06
136
561
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
104
300
3.65
30.90
1.3
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
778
5480
1.88
30.66
11.3
10.9
inr
1.2
1.3
2.64
208
1517
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
78
184
4.42
30.53
2.0
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
67
140
4.96
30.39
1.2
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
140
495
3.02
29.94
2.9
2.6
g/l
9.9
10.5
0.68
124
423
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
82
205
4.17
29.77
2.0
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
158
600
2.83
29.68
2.9
1.9
ug/l
1.7
1.9
0.13
141
528
(3000093) Morphology [Interpretation] in Blood Narrative
59
113
5.39
29.52
1.2
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
88
234
3.93
29.38
5.2
3.4
%
56.6
58.8
0.65
88
234
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
44
66
6.84
28.14
1.2
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
84
226
3.88
27.58
4.3
3.1
e9/l
3.4
4.4
3.91
84
226
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
23
14
16.67
27.20
1.7
1.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
121
416
3.08
27.13
3.2
2.4
g/l
35.6
37.1
1.53
110
358
(36304419) Bacteria [Presence] in Urine
532
3428
1.86
26.84
4.1
3.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
272
1390
2.17
26.63
5.3
2.8
umol/l
7.9
9.4
0.58
250
1221
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
111
371
3.15
26.10
3.3
2.5
g/l
0.0
0.0
0.00
105
337
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
100
314
3.34
26.05
1.6
2.0
mg/l
12.3
12.0
0.10
91
288
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
110
368
3.15
25.82
3.3
2.5
g/l
0.0
0.0
0.00
105
336
(3030467) Casts [#/volume] in Urine by Automated count
544
3564
1.83
25.78
4.1
3.3
e6/l
0.3
0.5
3.23
424
2755
(3042936) Bacteria identified in Isolate by Culture
333
1860
2.02
25.63
2.3
2.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
352
2005
1.99
25.63
3.0
2.0
s
30.0
29.9
0.06
343
1941
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
57
120
4.90
25.63
3.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
57
120
4.90
25.63
3.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
57
120
4.90
25.63
3.3
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
24
18
13.53
25.42
1.5
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
578
3898
1.79
24.59
4.3
3.4
e6/l
34.4
88.3
2.19
457
3068
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
29
31
9.52
24.46
1.4
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
473
3012
1.83
24.30
4.2
2.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
67
168
4.13
24.22
1.2
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
348
2025
1.94
23.58
2.6
2.5
umol/l
12.7
12.4
0.23
327
1860
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
314
1764
1.99
23.58
2.6
2.6
%
22.9
22.3
0.23
287
1492
(3018095) Leukocytes [#/volume] in Urine
636
4452
1.75
23.48
5.1
3.9
e6/l
67.5
111.0
1.11
475
3276
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
114
412
2.91
23.37
1.9
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
73
202
3.75
23.03
2.6
2.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
324
1869
1.94
22.40
2.6
2.5
g/l
2.2
2.3
2.23
303
1719
(3001964) Herpes simplex virus Ag [Presence] in Specimen
30
38
8.04
22.19
1.5
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
279
1540
2.00
21.88
1.5
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
39
67
5.95
21.88
1.5
1.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
122
482
2.67
21.11
1.6
1.9
u/l
41.8
38.9
0.69
101
421
(3021447) Carbon dioxide [Partial pressure] in Venous blood
235
1252
2.04
20.24
4.1
3.5
kpa
5.7
5.8
0.89
226
1211
(3002032) Base excess in Venous blood by calculation
233
1244
2.03
19.93
4.1
3.6
mmol/l
1.8
2.0
0.28
189
986
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
65
184
3.65
19.85
7.9
6.4
mg/l
12.0
12.0
0.01
58
171
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
39
74
5.38
19.72
3.8
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
39
74
5.38
19.72
3.8
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
39
74
5.38
19.72
3.8
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
39
74
5.38
19.72
3.8
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
75
237
3.28
19.34
1.6
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
26
33
8.00
19.19
4.2
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
166
790
2.24
19.09
1.9
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
117
483
2.54
18.50
3.0
3.1
u/ml
0.3
0.4
0.86
66
285
(3013826) Glucose [Moles/volume] in Serum or Plasma
918
7364
1.64
18.37
7.9
5.0
mmol/l
6.7
6.8
0.76
890
6912
(3026782) Osmolality of Urine
404
2630
1.73
18.37
3.5
2.8
mosm/kgh2o
543.0
555.4
0.62
353
2242
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
78
261
3.10
18.30
1.7
1.3
e6/l
15.3
42.7
0.59
64
205
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
30
48
6.36
18.05
1.4
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
136
611
2.35
17.88
4.1
3.7
mmol/l
24.2
24.1
0.04
123
550
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
33
59
5.70
17.78
4.2
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
33
59
5.70
17.78
4.2
1.9
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
77
261
3.06
17.67
1.8
1.3
e6/l
625.1
610.8
0.01
65
214
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
33
60
5.60
17.47
4.2
1.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
249
1425
1.90
17.25
2.7
4.1
ug/l
10.7
22.3
0.80
197
1187
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
96
374
2.67
17.06
1.9
1.6
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
22
7
31.87
17.05
1.1
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
35
69
5.17
16.99
2.2
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
35
69
5.17
16.99
2.2
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
33
62
5.42
16.88
2.4
2.4
u/ml
4622.1
1453.0
1.85
33
62
(3020779) Urea [Moles/volume] in Serum or Plasma
219
1212
1.95
16.75
8.0
7.4
mmol/l
10.5
10.6
0.05
209
1153
(3019832) Treponema pallidum Ab [Presence] in Serum
117
506
2.42
16.74
1.4
1.5
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
42
98
4.38
16.70
1.7
1.3
g/l
0.3
0.4
0.31
29
70
(3028192) IgG subclass 2 [Mass/volume] in Serum
42
98
4.38
16.70
1.7
1.3
g/l
2.5
2.8
0.36
31
72
(3027135) IgG subclass 1 [Mass/volume] in Serum
42
98
4.38
16.70
1.7
1.3
g/l
6.0
7.0
0.60
30
71
(3000850) Epithelial cells [#/volume] in Urine
413
2765
1.68
16.69
3.3
2.6
e6/l
4.3
5.2
0.99
371
2450
(4062490)
42
99
4.34
16.49
1.7
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
474
3299
1.64
16.42
2.4
2.2
mg/l
3.5
3.1
2.10
412
2765
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
327
2068
1.74
16.22
3.8
3.0
e6/l
2.1
2.2
0.10
183
1177
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
76
271
2.90
15.97
1.2
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
244
1427
1.85
15.70
2.0
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
37
82
4.60
15.69
2.1
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
37
82
4.60
15.69
2.1
1.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
74
263
2.91
15.64
1.6
1.2
mmol/l
3.8
3.9
0.12
69
247
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
338
2188
1.70
15.31
3.5
2.9
e6/l
1.3
1.1
0.55
195
1289
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
56
173
3.32
15.00
1.2
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
203
1136
1.91
14.95
7.1
8.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
44
116
3.88
14.91
1.4
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
965
8032
1.57
14.86
6.0
4.8
e6/l
255.6
2186.9
1.74
22
133
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
49
142
3.53
14.49
3.3
2.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
52
158
3.37
14.31
1.8
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
209
1198
1.87
14.26
2.3
2.2
g/l
0.2
0.2
0.40
191
1106
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
98
4.06
14.12
2.1
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
39
99
4.02
13.93
1.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
428
3012
1.59
13.71
1.6
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
53
168
3.23
13.65
1.7
1.7
g/l
0.6
0.9
1.35
40
131
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
32
71
4.58
13.57
1.2
1.1
mg/l
476.7
259.5
1.33
26
63
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
192
1089
1.88
13.51
8.6
4.0
mmol/l
1.2
1.2
0.43
186
938
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
83
341
2.52
13.27
3.1
2.3
%
91.6
88.6
0.53
83
326
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
32
73
4.46
13.12
1.3
1.1
mg/l
75.1
40.0
1.70
25
62
(3017732) Neutrophils [#/volume] in Blood
145
755
2.02
13.11
2.9
3.2
e9/l
3.8
4.1
0.81
102
556
(3037467) Urinalysis macro (dipstick) panel - Urine
977
8263
1.53
13.07
5.4
4.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
26
50
5.27
12.98
1.0
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
122
610
2.09
12.31
1.5
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
42
123
3.48
12.26
2.2
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
546
4140
1.50
12.16
4.1
3.2
ng/l
2179.7
1667.0
0.83
500
3559
(3014148) Varicella zoster virus Ab [Titer] in Serum
33
82
4.09
12.14
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
42
125
3.43
11.97
1.3
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
33
83
4.04
11.95
2.5
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
366
2562
1.57
11.72
2.0
1.8
mg/l
1.8
1.4
1.08
301
1985
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
153
851
1.89
11.40
2.0
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
50
171
2.99
11.37
1.1
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
49
166
3.02
11.33
1.7
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
190
1133
1.78
11.30
2.7
2.3
u/l
36.1
34.8
0.14
166
963
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
107
526
2.11
11.29
2.2
3.4
u/ml
66.9
7784.3
0.84
87
447
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
54
194
2.85
11.25
1.3
1.3
miu/ml
84.0
229.3
—
9
73
(3007853) Bacteria identified in Skin by Aerobe culture
232
1468
1.69
11.15
2.0
1.8
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
17
25
6.87
11.03
1.1
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
175
1028
1.80
10.94
3.2
2.9
kpa
4.6
4.5
0.31
168
991
(3001122) Ferritin [Mass/volume] in Serum or Plasma
610
4805
1.46
10.88
3.5
2.8
ug/l
383.3
146.9
6.64
568
4338
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
51
181
2.88
10.87
1.3
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
226
1435
1.68
10.70
1.4
1.3
titre
597.9
467.0
0.44
56
314
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
68
282
2.48
10.70
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
68
282
2.48
10.70
1.6
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
52
189
2.81
10.62
1.4
1.4
e6/l
1843.3
1683.1
0.14
37
137
(3014111) Lactate [Moles/volume] in Serum or Plasma
195
1192
1.73
10.61
6.3
7.0
mmol/l
1.7
1.4
1.36
190
1142
(3036489) Thrombin time
90
427
2.18
10.41
2.6
2.0
s
21.6
21.6
0.04
84
389
(3019225) pH of Specimen
207
1294
1.70
10.38
6.4
4.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
17
27
6.36
10.28
1.6
1.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
23
49
4.75
10.25
1.7
1.1
%
61.1
71.2
—
7
5
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
72
313
2.37
10.23
3.2
3.1
mg/l
1.7
1.7
0.03
67
281
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
15
21
7.21
10.14
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
18
31
5.87
10.07
1.0
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
21
42
5.06
10.06
1.5
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
76
342
2.29
9.99
1.4
1.6
iu/ml
0.1
17.7
0.49
22
68
(3026008) Bacteria identified in Urine by Culture
508
3924
1.45
9.79
3.8
3.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
601
4790
1.43
9.75
2.4
2.2
nmol/l
76.3
78.6
1.22
552
4181
(4027681)
24
56
4.34
9.60
1.5
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
348
2520
1.50
9.26
4.5
4.0
ng/l
757.7
327.2
0.40
300
2116
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
41
142
2.94
9.17
2.9
4.0
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
20
42
4.81
9.07
23.4
32.1
ug/l
7.0
7.1
0.08
14
37
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
104
549
1.96
9.06
3.2
2.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
11
12
9.23
8.98
1.2
1.1
%
102.5
96.8
0.16
11
12
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
11
12
9.23
8.98
1.2
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
17
31
5.54
8.98
1.4
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
30
88
3.46
8.79
1.3
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
249
1702
1.56
8.62
8.8
6.8
mmol/l
104.2
104.2
0.01
241
1658
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
71
332
2.20
8.55
1.8
1.5
g/l
0.2
0.2
0.36
63
315
(3009445) Proteinase 3 Ab [Units/volume] in Serum
100
532
1.94
8.53
1.1
1.4
—
23.0
—
0
14
(3028308) Erythrocytes [#/volume] in Pleural fluid
45
171
2.68
8.50
1.5
1.4
e6/l
33871.7
106074.6
0.96
24
104
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
62
275
2.31
8.46
1.6
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
95
498
1.97
8.45
2.0
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
619
5051
1.38
8.39
4.6
4.0
ng/l
63.8
51.9
0.18
511
3790
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
475
3715
1.41
8.25
5.8
3.2
u/l
33.9
33.9
0.00
452
3526
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
490
3854
1.40
8.23
3.4
2.5
u/l
50.5
57.7
5.73
462
3530
(3024891) Influenza virus A+B Ag [Presence] in Specimen
63
285
2.26
8.22
1.4
1.2
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
18
39
4.66
7.88
1.2
1.3
ug/l
10.5
78.6
—
7
19
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
209
1401
1.57
7.85
5.5
3.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
66
3.68
7.75
1.1
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
145
892
1.69
7.68
4.4
3.8
ph
7.4
7.4
0.48
21
116
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
146
902
1.69
7.61
4.5
3.8
kpa
5.0
5.2
1.34
141
842
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
30
97
3.14
7.58
1.1
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
21
55
3.86
7.26
7.0
3.0
u/l
232.0
214.3
0.30
21
55
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
138
854
1.68
7.15
4.3
3.8
mmol/l
2.3
1.9
0.73
107
651
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
24
70
3.47
7.13
1.3
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
237
1668
1.50
7.10
1.3
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
13
23
5.69
7.07
1.2
1.0
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
12
20
6.04
6.91
2.0
1.5
%
4.4
4.3
—
7
10
(3009214) Lutropin [Units/volume] in Serum or Plasma
48
212
2.31
6.68
1.4
1.3
u/l
11.2
9.8
0.32
38
166
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
65
326
2.04
6.60
1.1
1.2
—
13.0
—
0
5
(3009871) Measles virus Ab [Titer] in Serum
12
21
5.75
6.59
1.8
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
43
183
2.39
6.50
2.3
2.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
13
25
5.24
6.49
1.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
13
25
5.24
6.49
1.2
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
14
29
4.86
6.46
2.4
1.4
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
9
5
18.10
6.26
2.3
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
9
5
18.10
6.26
1.1
1.4
—
—
—
0
0
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
6
0
+∞
6.25
1.0
0.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
17
43
3.99
6.17
2.5
2.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
30
111
2.74
6.04
1.2
1.2
u/l
57.3
55.1
0.06
24
82
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
23
73
3.18
6.03
3.1
1.6
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
20
58
3.48
6.02
1.4
1.0
u/l
1.4
1.1
0.39
11
32
(1616796) Gas panel - Central venous blood
59
296
2.03
6.01
3.9
4.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
13
27
4.85
5.98
2.1
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
10
16
6.29
5.96
1.0
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
24
79
3.07
5.93
2.4
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
44
198
2.26
5.89
1.2
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
12
24
5.03
5.75
1.7
1.4
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
17
46
3.73
5.65
1.4
1.0
ng/l
3152.6
102.3
—
10
11
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
21
66
3.21
5.60
3.6
3.8
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
101
615
1.69
5.60
4.8
3.8
%
50.2
49.0
0.18
101
607
(3003396) Base excess in Arterial blood by calculation
220
1597
1.44
5.58
8.6
7.3
mmol/l
1.6
1.2
0.69
163
1232
(3022313) Gas panel - Capillary blood
106
655
1.67
5.56
4.8
3.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
31
122
2.57
5.56
1.9
1.9
u/l
656.7
1396.9
0.38
13
44
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
219
1591
1.44
5.53
8.5
7.3
kpa
5.0
5.1
0.75
200
1517
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
54
271
2.03
5.52
2.5
1.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
219
1592
1.44
5.52
8.5
7.3
kpa
12.2
11.9
0.39
202
1520
(3035350) Ketones [Presence] in Urine by Test strip
668
5753
1.29
5.50
4.5
3.9
estimate
0.0
0.0
0.00
156
1105
(40768443) Skin Pathology biopsy report
87
511
1.75
5.49
1.2
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
667
5749
1.29
5.43
6.2
5.3
estimate
0.0
0.0
0.00
158
1113
(3045788) Cell count panel - Pleural fluid
36
154
2.37
5.43
1.6
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
472
3895
1.31
5.32
2.4
2.2
u/l
136.0
235.2
4.08
443
3639
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
23
79
2.94
5.31
2.4
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
30
119
2.55
5.31
1.7
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
341
2690
1.35
5.26
1.9
1.8
nmol/l
1172.3
1181.6
0.06
268
2001
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
97
597
1.67
5.18
2.7
3.3
pmol/l
4.0
4.4
3.83
85
515
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
14
35
4.03
5.17
1.8
1.8
iu/ml
—
1424630.0
—
0
5
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
70
3.03
5.11
1.1
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
13
31
4.22
5.09
1.6
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
808
7172
1.28
5.07
4.0
3.2
u/l
59.1
54.1
0.67
761
6571
(3007566) Smooth muscle Ab [Titer] in Serum
56
294
1.94
5.07
1.1
1.2
titre
98.0
80.4
—
5
23
(3009261) Glucose [Presence] in Urine by Test strip
671
5826
1.28
5.03
4.7
3.9
estimate
0.0
0.0
0.80
157
1078
(3011397) Hemoglobin [Presence] in Urine by Test strip
347
2761
1.33
5.03
4.3
3.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
147
1006
1.51
5.02
3.4
3.7
ng/l
79.8
91.9
0.88
119
869
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
90
548
1.68
5.02
5.1
4.2
mmol/l
25.4
24.9
0.69
84
514
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
23
4.81
5.01
1.3
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
389
3159
1.31
4.86
1.7
1.6
nmol/l
19.7
20.5
0.51
334
2643
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
29
119
2.47
4.81
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
19
63
3.04
4.68
1.2
1.1
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
7
5
14.06
4.58
1.0
1.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
56
305
1.87
4.57
4.0
5.5
mmol/l
2.9
2.9
0.03
49
213
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
19
64
2.99
4.56
2.6
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
19
64
2.99
4.56
1.2
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
19
64
2.99
4.56
2.6
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
13
34
3.85
4.54
1.0
1.1
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
56
306
1.86
4.53
4.0
5.5
kpa
5.1
5.1
0.20
56
301
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
8
8
10.05
4.52
2.3
4.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
60
336
1.82
4.49
1.5
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
56
307
1.86
4.49
1.1
1.2
—
1293.0
—
0
10
(3027315) Oxygen [Partial pressure] in Blood
56
307
1.86
4.49
4.0
5.5
kpa
8.2
8.3
0.10
56
302
(3010421) pH of Blood
65
374
1.77
4.46
3.9
4.9
ph
7.4
7.4
0.21
56
300
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
12
30
4.02
4.44
1.8
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
39
190
2.08
4.37
1.3
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
13
35
3.74
4.37
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
32
144
2.25
4.36
1.4
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
28
121
2.34
4.19
1.2
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
9
13
6.96
4.16
1.7
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
26
109
2.41
4.16
1.1
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
192
1434
1.39
4.14
1.3
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
59
338
1.78
4.13
1.5
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
8
10
8.04
4.06
1.0
1.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
107
718
1.53
4.04
8.3
9.9
mmol/l
24.0
24.4
0.62
98
669
(42529406) Shigella sp [Presence] in Stool by Culture
59
341
1.76
4.01
1.5
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
36
177
2.06
3.97
1.6
1.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
53
299
1.80
3.91
1.5
1.2
u/ml
46.0
19.7
—
8
11
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
13
38
3.44
3.90
1.1
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
11
7.31
3.86
1.1
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1219
11545
1.30
3.81
38.0
16.5
mg/l
25.6
26.1
0.24
1129
9329
(46236302) HLA-C [Type] by High resolution typing
6
5
12.04
3.76
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
6
5
12.04
3.76
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
6
5
12.04
3.76
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
6
5
12.04
3.76
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
6
5
12.04
3.76
1.0
1.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
86
559
1.57
3.76
9.3
4.9
%
1.6
1.6
0.09
76
521
(3047189) Immunofixation for 24 hour Urine
18
66
2.75
3.76
1.8
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
62
372
1.70
3.72
3.0
3.4
mmol/l
24.8
25.1
0.23
57
318
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1096
11599
0.79
3.71
4.8
5.3
mmol/l
2.6
2.6
0.68
981
10478
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1021
10882
0.81
3.63
6.0
6.3
mmol/mol
40.5
40.6
0.16
919
9925
(3019060) Gas panel - Arterial blood
132
946
1.43
3.62
7.7
4.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
33
164
2.04
3.56
3.2
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
255
3153
0.77
3.56
1.8
1.6
mmol/l
1.4
1.4
1.00
229
2594
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
9
17
5.32
3.51
1.1
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
33
165
2.02
3.51
3.2
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
33
165
2.02
3.51
3.2
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
33
166
2.01
3.46
3.2
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
33
166
2.01
3.46
3.2
1.5
—
—
—
0
0
(3013512) EKG study
445
3812
1.24
3.43
5.1
4.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
346
4106
0.80
3.42
4.0
4.0
mg/mmol
11.3
9.3
0.35
232
2610
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
49
283
1.76
3.39
1.5
1.2
u/ml
3.3
2.7
—
8
27
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
14
5.74
3.34
1.1
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
89
602
1.51
3.29
1.3
1.2
u/ml
99.3
233.6
1.81
81
545
(3020393) Adenovirus Ag [Presence] in Stool
6
7
8.60
3.26
1.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1073
11336
0.81
3.24
4.4
4.7
mmol/l
4.4
4.5
1.95
958
10313
(21494890) Protein electrophoresis panel - 24 hour Urine
29
143
2.05
3.22
2.0
2.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
49
288
1.73
3.20
1.5
1.2
u/ml
1.6
9.1
—
10
42
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1062
11228
0.81
3.20
4.3
4.6
mmol/l
1.4
1.4
7.85
944
10121
(3016502) Oxygen saturation in Arterial blood
186
1441
1.33
3.20
9.6
7.6
%
95.0
95.3
0.23
174
1387
(3012516) Albumin [Mass/volume] in Urine
327
3879
0.80
3.19
3.2
3.3
mg/l
1176.6
295.5
1.24
215
2482
(3036481) Cortisol [Moles/volume] in Serum or Plasma
142
1058
1.38
3.14
3.0
2.1
nmol/l
364.7
371.3
0.17
135
956
(3024522) Salmonella sp identified in Specimen by Organism specific culture
32
166
1.95
3.10
3.2
1.5
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
39
3.09
3.09
1.1
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
14
50
2.82
3.09
1.1
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
44
254
1.75
3.07
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
99
2.24
3.07
1.1
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
43
247
1.76
3.05
1.3
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
40
226
1.79
3.01
1.2
1.2
u/l
38.6
45.5
0.20
33
195
(1761868) Lipid panel - Serum or Plasma
300
3568
0.80
2.97
2.8
3.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
49
295
1.68
2.96
1.8
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
70
463
1.54
2.90
2.2
3.1
g/l
0.7
0.3
0.82
38
180
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
599
5357
1.20
2.89
2.2
2.1
pmol/l
92.2
93.9
0.37
335
2772
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
58
2.60
2.87
1.1
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
75
505
1.51
2.86
1.9
1.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
45
269
1.69
2.81
3.0
3.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
38
217
1.77
2.78
1.5
1.3
iu/l
25.8
26.3
0.04
33
183
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
24
117
2.07
2.78
1.1
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
6
8.36
2.75
1.6
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
19
4.23
2.68
1.9
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
343
3983
0.82
2.66
3.0
3.2
mmol/l
6.9
7.4
1.45
291
3275
(3043410) Blood group antigens tested for on Red Blood Cells
12
43
2.81
2.65
2.6
2.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
32
3.14
2.65
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
166
1302
1.31
2.64
1.3
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
55
353
1.58
2.62
2.0
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
371
3200
1.21
2.59
5.1
4.2
estimate
0.0
0.0
0.37
152
1063
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
38
2.91
2.58
1.1
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
341
3951
0.82
2.58
3.8
4.5
%
21.3
21.4
0.06
162
2014
(3002173) Hemoglobin [Mass/volume] in Arterial blood
167
1317
1.30
2.56
10.3
7.9
g/l
110.6
120.9
8.14
156
1268
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
38
223
1.72
2.55
3.1
3.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
11
5.47
2.54
1.5
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
11
5.47
2.54
1.5
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
11
5.47
2.54
1.5
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
11
5.47
2.54
4.0
5.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
128
973
1.35
2.53
3.3
3.0
ml/min/173m2
59.0
62.1
0.33
58
404
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
56
2.51
2.53
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
56
2.51
2.53
1.1
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
22
108
2.05
2.52
1.3
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
993
9344
1.19
2.52
42.2
19.9
%
14.5
13.8
26.73
982
9118
(3051651) Icteric interference index of Serum or Plasma
18
82
2.21
2.48
6.2
3.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
14
57
2.47
2.45
1.2
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
153
1206
1.30
2.36
3.4
3.1
ng/l
328.7
229.5
1.32
142
1108
(3032057) Clostridioides difficile [Presence] in Stool
10
35
2.87
2.30
2.0
2.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
13
53
2.47
2.28
1.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
16
72
2.24
2.28
1.7
2.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
13
4.63
2.27
1.5
1.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
78
557
1.42
2.27
10.0
4.9
%
0.8
0.9
1.14
70
520
(3036603) Volume of Urine
16
73
2.20
2.21
1.5
1.4
ml
1388.8
1829.3
—
5
15
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
35
210
1.68
2.21
1.1
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
36
2.79
2.20
1.2
1.1
miu/ml
1302.1
1631.1
—
10
36
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
19
3.70
2.15
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
133
1046
1.30
2.11
5.2
4.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
71
506
1.42
2.11
2.0
2.2
ug/l
626.5
501.9
0.11
65
478
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
102
1.97
2.10
2.8
2.2
u/field
1.5
2.0
—
10
39
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
25
3.21
2.09
1.1
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
31
2.91
2.07
1.1
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
115
890
1.32
2.06
10.5
6.5
mmol/l
25.4
24.5
1.24
104
829
(3017569) Oxygen content in Arterial blood
15
69
2.19
2.05
1.7
2.7
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
26
3.09
2.01
3.6
4.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
57
396
1.46
1.95
4.8
3.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
18
91
1.99
1.95
1.2
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
23
127
1.82
1.94
1.3
1.6
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
11
4.56
1.94
1.0
1.2
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
7
22
3.19
1.88
12.9
2.0
—
40.9
—
0
8
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
46
2.40
1.85
1.3
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
17
3.54
1.84
1.5
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
12
4.18
1.82
3.6
3.5
u/field
0.2
0.5
—
5
12
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
648
5991
1.14
1.82
2.9
2.5
—
—
—
0
0
(4024509)
21
116
1.82
1.79
1.5
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
47
674
0.69
1.77
1.6
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
44
297
1.50
1.76
3.2
2.6
%
15.3
15.9
0.43
25
154
(3023183) Ammonium ion [Moles/volume] in Plasma
43
289
1.50
1.76
3.2
3.0
umol/l
32.4
34.9
0.32
37
239
(3028271) Lactate [Moles/volume] in Capillary blood
35
225
1.57
1.74
2.1
2.0
mmol/l
1.6
1.7
0.41
35
219
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
13
3.85
1.71
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
14
68
2.07
1.70
3.3
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
76
1.98
1.64
1.7
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
15
76
1.98
1.64
1.7
2.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
25
150
1.68
1.64
1.1
1.1
—
10.7
—
0
5
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
462
0.64
1.63
1.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
43
2.33
1.60
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
70
2.01
1.59
1.5
1.6
u/l
10.8
8.4
—
9
39
(3008295) Osmolality of Serum or Plasma
24
145
1.67
1.54
1.4
1.3
mosm/kgh2o
272.8
277.8
0.56
16
107
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
44
2.28
1.53
3.1
2.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
65
487
1.35
1.51
1.6
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
15
79
1.91
1.49
2.6
2.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
42
293
1.45
1.47
2.5
2.3
g/l
125.4
128.7
0.37
32
219
(21494755) Public health laboratory ask at order entry panel
44
614
0.71
1.47
1.3
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1128
10894
1.14
1.46
32.1
15.3
ml/min/173m2
75.4
75.9
0.27
1036
9007
(3024928) Oxygen saturation in Venous blood
41
285
1.45
1.46
1.8
2.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
85
667
1.29
1.44
3.9
3.9
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
16
3.13
1.44
1.0
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
289
0.58
1.42
1.4
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1048
10860
0.88
1.41
4.0
4.1
mmol/l
1.3
1.3
1.59
934
9710
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
29
2.42
1.39
1.1
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
28
182
1.55
1.37
2.9
2.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
92
738
1.26
1.33
14.1
10.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
428
0.67
1.33
1.4
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
91
730
1.26
1.32
1.2
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
18
2.78
1.28
1.2
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
114
1.68
1.28
1.3
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
9
44
2.05
1.27
1.3
1.2
—
14.6
—
0
9
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
27
178
1.53
1.26
2.3
2.5
mg/l
24.1
24.8
—
7
45
(3014891) Appearance of Pleural fluid
6
25
2.41
1.24
1.5
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
22
139
1.59
1.23
6.0
3.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
253
2834
0.87
1.23
2.7
3.2
ug/l
0.7
0.8
0.96
164
1977
(3043409) Potassium [Moles/volume] in Arterial blood
56
428
1.32
1.19
4.9
3.9
mmol/l
3.9
3.9
0.47
49
396
(3002619) Bacteria identified in Specimen by Culture
6
26
2.31
1.18
1.2
1.1
—
—
—
0
0
(4281824)
20
125
1.61
1.18
1.2
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
20
2.50
1.15
1.2
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1240
12669
0.88
1.14
50.3
24.0
e9/l
6.9
6.8
0.30
1216
12239
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
144
1233
1.19
1.14
2.3
2.5
ug/l
11.5
7.2
0.57
125
1079
(3000963) Hemoglobin [Mass/volume] in Blood
1240
12668
0.88
1.14
50.7
24.1
g/l
126.0
134.0
53.07
1231
12421
(3026361) Erythrocytes [#/volume] in Blood
1240
12667
0.88
1.13
50.3
23.9
e12/l
4.2
4.4
38.84
1215
12235
(3035941) MCH [Entitic mass]
1240
12666
0.88
1.12
50.1
23.8
pg
30.5
30.4
0.23
1235
12416
(3024731) MCV [Entitic volume]
1240
12665
0.88
1.12
50.2
23.9
fl
91.9
91.5
2.26
1235
12418
(3020891) Body temperature
70
557
1.27
1.12
6.6
4.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
51
1.97
1.11
1.4
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1240
12664
0.88
1.11
50.4
23.9
e9/l
221.3
243.3
23.29
1222
12276
(3044889) 12 lead EKG panel
885
8493
1.10
1.10
5.1
4.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
66
1.82
1.09
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
66
1.82
1.09
1.1
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
13
217
0.60
1.06
1.7
1.7
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
104
871
1.21
1.06
9.6
9.2
%
93.7
93.8
0.08
104
863
(3041096) Erythrocytes [Presence] in Urine by Automated
333
3045
1.12
1.06
4.5
3.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
33
2.13
1.05
1.4
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
18
114
1.59
1.02
1.3
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
47
360
1.32
1.01
3.9
5.0
—
—
—
0
0
(1002224) Polysomnography panel
25
356
0.70
1.00
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
895
8625
1.09
0.96
4.2
3.9
pmol/l
15.1
15.0
0.42
806
7683
(3022217) INR in Platelet poor plasma by Coagulation assay
208
1861
1.14
0.95
29.5
28.2
inr
1.5
1.4
0.45
26
244
(3009542) Hematocrit [Volume Fraction] of Blood
1047
10170
1.10
0.92
33.3
17.8
%
37.0
39.1
8.56
701
6600
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
75
618
1.22
0.92
1.1
1.2
iu/ml
63.7
143.5
1.81
16
240
(40768800) Prostate Pathology biopsy report
23
326
0.70
0.92
1.2
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
28
2.15
0.91
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
30
2.00
0.87
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
30
2.00
0.87
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
30
2.00
0.87
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
30
2.00
0.87
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
14
216
0.64
0.86
1.4
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
19
128
1.49
0.86
1.3
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
21
298
0.70
0.85
1.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
47
371
1.28
0.84
1.4
1.5
ug/g
241.1
284.0
0.82
28
229
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
463
4914
0.92
0.84
4.3
5.3
ug/l
3.8
3.0
0.26
401
4345
(3006653) Thiamine [Moles/volume] in Blood
11
65
1.70
0.82
1.5
1.2
nmol/l
138.2
141.5
0.13
11
65
(3039000) Anion gap in Blood
40
311
1.29
0.81
16.1
6.4
mmol/l
9.9
11.2
1.82
32
277
(3018572) Chloride [Moles/volume] in Blood
40
311
1.29
0.81
16.1
6.4
mmol/l
106.5
105.4
0.68
32
277
(3019977) pH of Arterial blood
13
81
1.61
0.81
3.5
3.2
ph
7.4
7.4
—
7
26
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
470
4432
1.09
0.80
5.1
4.2
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.8
—
2.3
—
0
11
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
34
1.77
0.76
1.3
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
32
245
1.31
0.74
1.5
1.3
mmol/l
57.1
60.1
0.18
27
198
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
51
620
0.82
0.72
1.6
1.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
26
1.93
0.70
1.2
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
51
418
1.23
0.70
13.6
6.0
mmol/l
1.2
1.4
0.94
40
365
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
177
1604
1.12
0.69
12.1
8.1
—
—
—
0
0
(4306422)
19
135
1.41
0.69
1.3
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
42
1.67
0.68
2.0
2.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
20
144
1.39
0.68
1.0
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
304
2835
1.09
0.68
1.7
1.7
pmol/l
438.1
18082739.9
1.66
257
2284
(3000285) Sodium [Moles/volume] in Blood
5
28
1.79
0.66
1.4
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
28
1.79
0.66
1.4
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
93
811
1.16
0.66
3.7
3.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
62
1.62
0.65
4.7
7.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1115
11364
0.93
0.64
5.0
4.9
mmol/l
6.0
6.0
0.79
1008
10151
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
138
1.38
0.62
1.2
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
11
71
1.55
0.62
1.0
2.1
umol/l
4.3
8.6
—
5
45
(3050129) First trimester maternal screen panel - Serum or Plasma
6
103
0.58
0.62
1.3
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
37
298
1.25
0.61
3.8
3.8
mg/l
26.8
27.9
0.07
30
190
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
47
564
0.83
0.60
1.6
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
21
158
1.33
0.57
1.1
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
31
247
1.26
0.57
1.1
1.2
—
456.7
—
0
6
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
16
115
1.40
0.56
2.0
1.4
%
39.5
26.6
0.52
11
74
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
160
1746
0.91
0.55
1.2
1.2
u/ml
13.1
13.4
0.02
56
614
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
22
168
1.31
0.55
1.1
1.1
g/l
1.6
1.6
0.03
22
150
(4094501)
37
303
1.23
0.54
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
68
590
1.16
0.54
2.9
2.7
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
38
1.58
0.54
1.0
1.0
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
60
1.50
0.54
1.4
1.3
ug/l
9.9
7.4
—
9
52
(3014051) Protein [Presence] in Urine by Test strip
35
286
1.23
0.53
2.2
2.2
—
—
—
0
0
(4268621)
14
100
1.40
0.52
2.0
2.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
203
0.74
0.51
1.3
1.9
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
41
1.47
0.50
1.0
1.9
ug/l
13.3
230.7
—
6
33
(40761511) CBC panel - Blood by Automated count
1173
11898
0.93
0.49
28.4
15.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
87
777
1.13
0.48
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
102
1128
0.90
0.47
1.6
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
68
1.47
0.47
2.8
1.7
g/l
0.9
1.0
—
10
68
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
48
1.46
0.46
3.9
2.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
49
1.43
0.46
1.1
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
77
685
1.13
0.45
2.4
2.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
51
1.37
0.44
2.7
3.0
—
—
—
0
0
(4211845)
8
58
1.38
0.41
2.5
2.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
117
1074
1.10
0.41
4.2
3.6
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.1
—
875.7
—
0
5
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
95.9
—
0
16
(3009015) Lactate [Moles/volume] in Synovial fluid
0
17
0.00
0.40
0.0
1.4
—
6.9
—
0
10
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
2.1
—
0.7
—
0
10
(40768793) Breast Pathology biopsy report
29
241
1.21
0.40
1.6
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
12
88
1.37
0.40
1.7
1.7
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
12
89
1.35
0.38
1.3
1.1
mmol/l
31.5
34.8
0.25
12
80
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
18
143
1.26
0.37
1.3
1.2
u/ml
2.9
5.6
—
8
69
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
18
143
1.26
0.37
1.3
1.2
u/ml
1.2
3.8
—
5
49
(4010399)
96
879
1.10
0.37
1.4
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
81
1.36
0.36
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
81
1.36
0.36
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
81
1.36
0.36
1.3
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
42
1.43
0.35
2.3
1.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
190
1795
1.07
0.35
1.2
1.3
iu/ml
59.9
33.7
0.66
60
555
(4015189)
6
44
1.37
0.34
1.2
2.0
—
—
—
0
0
(4034850)
32
372
0.86
0.34
15.2
12.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
82
1.34
0.34
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
82
1.34
0.34
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
82
1.34
0.34
1.3
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
45
1.33
0.33
1.0
1.2
iu/ml
108.5
243.3
—
6
45
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21
253
0.83
0.33
1.3
1.9
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
49
435
1.13
0.33
1.0
1.1
—
178.0
—
0
12
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
86
0.70
0.33
1.8
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
86
0.70
0.33
1.8
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
86
0.70
0.33
1.8
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
86
0.70
0.33
1.8
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
88
0.68
0.33
1.7
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
137
1.24
0.32
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
52
1.35
0.31
1.1
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
142
0.77
0.30
1.5
1.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
12
153
0.78
0.30
1.4
1.3
nmol/l
0.6
0.7
0.47
12
143
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
54
1.30
0.30
1.3
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
84
1.31
0.30
1.2
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
12
152
0.79
0.29
1.4
1.3
—
0.5
—
0
13
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
8
109
0.73
0.29
1.5
1.2
nmol/l
2.0
1.5
—
8
94
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
7
57
1.23
0.29
1.0
1.1
—
11.3
—
0
16
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
167
1.20
0.28
1.7
1.5
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
8
62
1.29
0.28
1.3
1.2
u/l
174.5
411.1
—
8
54
(3021387) Prolactin [Units/volume] in Serum or Plasma
26
224
1.16
0.27
1.7
1.7
mu/l
337.3
294.7
0.34
26
203
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
117
1243
0.94
0.26
1.5
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
87
1.27
0.24
2.3
2.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
81
0.74
0.24
2.2
2.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
84
0.71
0.24
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
201
0.84
0.23
1.4
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
22
254
0.86
0.23
1.2
1.1
—
8.9
—
0
21
(3003338) MCHC [Mass/volume]
921
9322
0.97
0.23
43.4
21.5
g/l
330.5
331.9
4.63
916
9238
(3017446) Testosterone [Moles/volume] in Serum or Plasma
93
874
1.07
0.22
2.2
2.2
nmol/l
12.3
12.9
0.24
79
757
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
93
0.75
0.22
1.4
1.1
—
81.2
—
0
9
(3027944) Amphetamines [Presence] in Urine
16
189
0.84
0.22
1.1
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
15
178
0.84
0.22
1.1
1.9
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
11
0.00
0.21
0.0
14.2
—
—
—
0
0
(3025315) Body weight
0
10
0.00
0.21
0.0
5.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(4146454)
13
156
0.83
0.21
3.7
2.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
24.9
—
0
12
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
126
1201
1.05
0.20
2.1
2.2
ug/g
159.8
152.5
0.09
104
946
(3032868) Hemoglobin electrophoresis panel in Blood
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
41
375
1.10
0.19
1.6
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
133
0.83
0.19
1.2
1.3
nmol/l
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
230
2228
1.04
0.19
1.3
1.2
u/ml
1.0
1.7
1.18
48
563
(3001019) Free T4 and TSH panel - Serum or Plasma
31
342
0.90
0.18
1.8
1.7
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
7
58
1.21
0.18
2.6
2.2
e6/l
576.9
919.0
—
7
49
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
7
58
1.21
0.18
2.1
2.1
umol/l
46.7
50.1
—
7
41
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
59
1.19
0.18
1.1
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1231
12237
1.03
0.18
22.5
11.0
u/l
26.5
25.5
0.61
1217
11732
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
153
0.85
0.18
2.4
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
32
351
0.91
0.17
1.6
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
10
82
1.22
0.17
1.2
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
71
1.13
0.16
1.1
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
28
254
1.10
0.16
1.5
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
163
1576
1.04
0.16
4.6
4.8
%
30.7
32.8
1.88
109
1013
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
109
1137
0.96
0.16
2.0
1.8
%
1.4
1.6
1.47
88
958
(3005570) Glucose [Moles/volume] in Urine
12
140
0.86
0.15
1.7
2.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
150
0.87
0.14
1.2
1.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
93
1.18
0.14
1.0
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1221
12150
1.03
0.14
37.3
19.3
mmol/l
139.3
139.6
4.08
1212
11810
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
10
84
1.19
0.14
1.2
1.6
umol/l
15.0
14.4
—
10
79
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
31
336
0.92
0.14
2.4
2.4
ug/min
118.9
115.7
0.02
17
199
(3000492) Spirometry study
96
1000
0.96
0.13
1.7
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
190
0.89
0.13
1.1
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
188
0.90
0.11
1.1
1.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
262
2576
1.02
0.10
5.0
4.3
kg/l
1.0
1.0
0.48
48
369
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
45
1.11
0.09
10.0
20.3
nmol/l
1906.8
1567.9
—
5
45
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
46
1.09
0.09
5.4
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
46
1.09
0.09
5.4
2.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1222
12176
1.02
0.09
38.0
19.5
mmol/l
4.0
4.0
0.17
1209
11818
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1047
10518
0.98
0.09
5.1
4.7
mu/l
2.1
2.1
0.01
955
9430
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
64
0.78
0.08
1.2
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
36
343
1.05
0.07
2.4
3.2
nmol/l
1.1
0.8
0.60
25
269
(3028707) Methadone [Presence] in Urine by Screen method
9
88
1.02
0.07
1.0
2.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1227
12241
1.01
0.06
40.1
19.3
umol/l
85.2
82.1
1.50
1227
12236
(3000475) Leukocytes [#/volume] in Synovial fluid
30
314
0.95
0.05
2.1
1.7
e6/l
11355.9
15899.1
0.42
25
230
(3011648) Oxygen content in Venous blood
11
100
1.10
0.05
1.6
1.9
%
12.5
10.9
0.54
11
100
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
62
604
1.03
0.05
1.3
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
23
242
0.95
0.05
1.7
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
18
190
0.95
0.04
1.1
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
15
143
1.05
0.01
1.8
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
183
1.04
0.01
2.0
1.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
25
244
1.03
0.00
2.4
1.5
nmol/l
1.0
0.8
0.41
17
201
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
12
121
0.99
0.00
1.1
1.2
mmol/l
9.6
7.5
—
7
83
(3011288) Drugs identified in Urine by Screen method
13
129
1.01
0.00
1.2
2.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
131
0.99
0.00
1.2
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
16
159
1.01
0.00
1.9
1.6
%
44.8
65.0
—
9
103
(3024263) Appearance of Synovial fluid
7
72
0.97
0.00
1.4
1.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
9
97
0.93
0.00
1.1
1.1
—
149.5
—
0
19
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
2.6
—
0
7
(3032773) Endomysium IgG Ab [Titer] in Serum
8
83
0.96
0.00
1.0
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
3.8
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
362.6
—
0
5
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
-0.00
0.0
4.5
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
-0.00
0.0
1.7
—
370.3
—
0
6
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
-0.00
0.0
1.0
—
7.4
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_NONHODGKIN_NAS – Other and unspecified types of non-Hodgkin lymphoma, hilmo
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).